IMA

6.07

1.17% 0.07

Handel nachbörslich: 5.97 -0.10 -1.65%

Imagenebio Inc (IMA)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

$6.00

Offen:

$5.956

24-Stunden-Volumen:

6,019

Relative Volume:

0.02

Marktkapitalisierung:

$68.46M

Einnahmen:

$800.00K

Nettoeinkommen (Verlust:

$-45.07M

KGV:

-1.1544

EPS:

-5.2583

Netto-Cashflow:

$-52.08M

1W Leistung:

+2.88%

1M Leistung:

+7.43%

6M Leistung:

-10.34%

1J Leistung:

+0.00%

1-Tages-Spanne:

$5.87

$6.07

1-Wochen-Bereich:

$5.56

$6.07

52-Wochen-Spanne:

$3.94

$17.96

Imagenebio Inc Stock (IMA) Company Profile

Firmenname

Imagenebio Inc

Sektor

Healthcare (1094)

Branche

Biotechnology (615)

Telefon

857-343-8292

Adresse

12526 HIGH BLUFF DRIVE, SAN DIEGO

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-07-23

Neueste SEC-Einreichungen

IMA's Discussions on Twitter

Compare IMA vs VRTX, REGN, ARGX, ALNY, RVMD

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IMA Imagenebio Inc	6.07	67.67M	800.00K	-45.07M	-52.08M	-5.2583
VRTX Vertex Pharmaceuticals Inc	522.25	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	676.23	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	919.94	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	321.59	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.46	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Imagenebio Inc Stock (IMA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-11-25	Fortgesetzt	Wedbush	Underperform
2025-10-24	Eingeleitet	Leerink Partners	Outperform

Imagenebio Inc Aktie (IMA) Neueste Nachrichten

07:21 AM

ImageneBio Appoints Matt Robbins as General Counsel - The Manila Times

07:21 AM

06:44 AM

Enterprise value to revenue forward of ImageneBio, Inc. – NASDAQ:IMA - TradingView

06:44 AM

Jul 05, 2026

Enterprise value to EBIT forward of ImageneBio, Inc. – BOATS:IMA - TradingView

Jul 05, 2026

Jun 30, 2026

IMA Stock Surges 24%, Breaks 50-DMA For First Time Since February – What's Driving The Rally? - Stocktwits

Jun 30, 2026

Jun 29, 2026

ImageneBio (IMA) prospectus supplement registers 2.5M shares for resale - Stock Titan

Jun 29, 2026

Jun 28, 2026

Enterprise value to EBITDA forward of ImageneBio, Inc. – BOATS:IMA - TradingView

Jun 28, 2026

Jun 26, 2026

ImageneBio Announces Upcoming Transition in Financial Leadership - TipRanks

Jun 26, 2026

Imagenebio (NASDAQ: IMA) finance chief Robert Lally to step down - Stock Titan

Jun 26, 2026

Imagenebio, Inc. Announces Resignation of Robert Lally as Senior Vice President of Finance and Operations, Effective July 22, 2026 - marketscreener.com

Jun 26, 2026

Jun 25, 2026

ImageneBio, Inc. Actuals & Estimates (NASDAQ:IMA) - TradingView

Jun 25, 2026

IMA Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 21, 2026

ImageneBio Ord Shs (IMA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 21, 2026

ImageneBio Ord Shs (IMA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 21, 2026

Jun 18, 2026

ImageneBio Shareholders Back Directors and Governance Proposals - The Globe and Mail

Jun 18, 2026

ImageneBio stockholders approve equity plan amendment and elect directors By Investing.com - Investing.com India

Jun 18, 2026

ImageneBio Ord Shs (IMA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 18, 2026

Jun 17, 2026

ImageneBio stockholders approve equity plan amendment and elect directors - Investing.com UK

Jun 17, 2026

ImageneBio Ord Shs (IMA) Institutional Confidence - TradingKey

Jun 17, 2026

ImageneBio Ord Shs (IMA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 12, 2026